Humana Inc.
$216
▼
-0.63%
2026-04-22 10:12:13
www.humana.com
NYQ: HUM
Explore Humana Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$26.04 B
Current Price
$216
52W High / Low
$315.35 / $163.11
Stock P/E
21.97
Book Value
$146.42
Dividend Yield
1.68%
ROCE
—
ROE
7.04%
Face Value
—
EPS
$9.83
Exp Qtr EPS
—
Sector
Healthcare
Industry
Healthcare Plans
Employees
67,060
Beta
0.45
Debt / Equity
74.81
Current Ratio
2
Quick Ratio
—
Forward P/E
12.61
Price / Sales
0.18
Enterprise Value
$16.62 B
EV / EBITDA
4.66
EV / Revenue
0.13
Rating
Hold
Target Price
$211.21
EPS Forecast (FY)
—
Pros
- Core market and financial snapshot is available for screening.
Cons
- Return on equity is on the weaker side.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | CVS Health Corporation | $77.63 | 55.78 | $99.22 B | 3.47% | 6.3% | 2.29% | $85.15 / $58.35 | $59.18 |
| 2. | Oscar Health, Inc. | $16.44 | — | $4.9 B | — | — | -44.35% | $23.8 / $10.69 | $3.29 |
| 3. | Alignment Healthcare, Inc. | $21.56 | — | $4.34 B | — | 2.9% | -0.7% | $23.87 / $11.62 | $0.88 |
| 4. | The Cigna Group | $279.79 | 12.61 | $73.76 B | 2.24% | — | 15.13% | $350 / $239.51 | $158.32 |
| 5. | Molina Healthcare, Inc. | $153.28 | 17.21 | $8.02 B | — | 9.53% | 11.02% | $333.22 / $121.06 | $79.78 |
| 6. | Progyny, Inc. | $18.64 | 24.25 | $1.42 B | — | 15.79% | 12.48% | $28.75 / $16.1 | $6.24 |
| 7. | Clover Health Investments, Corp. | $2.23 | — | $1.15 B | — | -25.75% | -26.33% | $3.92 / $1.58 | $0.59 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 32.52 B | 32.65 B | 32.39 B | 32.11 B | 29.21 B | — |
| Operating Profit | -865 M | 302 M | 898 M | 1.85 B | -698 M | — |
| Net Profit | -796 M | 195 M | 545 M | 1.24 B | -693 M | — |
| EPS in Rs | -6.63 | 1.62 | 4.54 | 10.36 | -5.77 | 3.98 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 129.66 B | 117.76 B | 106.37 B | 92.87 B |
| Operating Profit | 2.19 B | 2.38 B | 3.88 B | 3.97 B |
| Net Profit | 1.19 B | 1.21 B | 2.49 B | 2.81 B |
| EPS in Rs | 9.9 | 10.05 | 20.73 | 23.37 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 48.91 B | 46.48 B | 47.06 B | 43.05 B |
| Total Liabilities | 31.17 B | 30.03 B | 30.75 B | 27.68 B |
| Equity | 17.66 B | 16.38 B | 16.26 B | 15.31 B |
| Current Assets | — | — | — | — |
| Current Liabilities | — | — | — | — |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 921 M | 2.97 B | 3.98 B | 4.59 B |
| Investing CF | 2.27 B | -2.95 B | -3.49 B | -1.01 B |
| Financing CF | -1.22 B | -2.49 B | -856 M | -1.91 B |
| Free CF | 375 M | 2.39 B | 2.98 B | 3.45 B |
| Capex | -546 M | -575 M | -1 B | -1.14 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 10.11% | 10.7% | 14.54% | — |
| Earnings Growth % | -1.57% | -51.51% | -11.3% | — |
| Profit Margin % | 0.92% | 1.02% | 2.34% | 3.02% |
| Operating Margin % | 1.69% | 2.02% | 3.64% | 4.27% |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-27 | $0.885 |
| 2025-12-26 | $0.885 |
| 2025-09-26 | $0.885 |
| 2025-06-27 | $0.885 |
| 2025-03-28 | $0.885 |
Stock Splits
No stock split history available.